PARSIPPANY, NJ--(Marketwire - Jan 8, 2013) - Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior experts of Ogilvy & Mather (www.ogilvy.com), today announced that John Nosta, EVP, Strategy of Ogilvy CommonHealth Specialty Marketing in Parsippany topped the Pharma100 List for December 2012, according to Henry Gazay, founder of Medimix International (a marketing research solution provider for the healthcare industry, located in Miami, FL), who developed this social media ranking list. The list summarizes the top 100 social media influencers in the pharmaceutical industry.
Ogilvy CommonHealth Worldwide is a WPP company (NASDAQ: WPPGY) (www.wpp.com). The organization houses and maintains individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities within the marketplace.
Henry Gazay created the Pharma100 List to highlight the continually growing pharmaceutical industry and the numerous influencers actively engaging with consumers regarding healthcare and wellness. The ranking is determined by the most number of nominations submitted through Twitter from December 25th to December 31st. The voting was a global initiative on Twitter and included votes from every continent.
"Driving behavior in today's digital world requires a high level of engagement. Ogilvy CommonHealth Worldwide has made a commitment to establish our voice as second to none," Mr. Nosta (@JohnNosta) shared. "I feel honored that the pharma community recognizes my contribution to the industry."
Ogilvy CommonHealth Worldwide is committed to creativity and effectiveness in healthcare communications, everywhere. With 63 offices across 33 countries, the group provides marketing services including brand identity and development, clinical trial recruitment, digital/interactive services, direct-to-consumer, direct-to-patient, global integration, managed care marketing, market research and analytics, media planning and buying, medical advertising and promotion, medical education, public affairs and relations, relationship marketing, and strategic consulting. The network also offers scientific communications and publications services through a wholly owned separate legal entity.